VF
EPZM

Virtu Financial’s Epizyme, Inc EPZM Stock Holding History

Virtu Financial’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-70,012
Closed -$81K – 2368
2022
Q1 		$81K Buy
70,012
+27,262
+64% +$44.4K 0.01% 1020
2021
Q4 		$107K Buy
+42,750
New +$168K 0.01% 1112
2021
Q3 		– Sell
-28,568
Closed -$237K – 2243
2021
Q2 		$237K Buy
+28,568
New +$241K 0.02% 874
2020
Q4 		– Sell
-19,347
Closed -$231K – 1927
2020
Q3 		$231K Buy
+19,347
New +$259K 0.04% 541
2019
Q3 		– Sell
-16,727
Closed -$210K – 1978
2019
Q2 		$210K Buy
+16,727
New +$215K 0.01% 1006

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu Financial's EPZM Position: Q2 2022 in Review

Virtu Financial sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 70,012 shares — an estimated $81K sold.

Virtu Financial first reported a position in EPZM in Q2 2019 and held it in 5 quarters. The position peaked at $237K in Q2 2021. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.

  • Virtu Financial reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
  • Virtu Financial sold 70,012 Epizyme, Inc shares in Q2 2022, an estimated $81K.
  • Virtu Financial first reported a position in Epizyme, Inc in Q2 2019 and held it in 5 quarters.
  • Virtu Financial's Epizyme, Inc position peaked at $237K in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.

Based on Virtu Financial's 13F filing for Q2 2022, filed 9 Aug 2022.